Table 4.

Effect of GSH-E and SIN-1 i.p.v. administration in the hepatic GSH content

	GSH-E IPV (mmol kg−1)
	0.1 (n=4)	0.25 (n=4)	0.5 (n=5)	1.0 (n=8)	2.0 (n=4)
Hepatic GSH (μmol g fresh liver−1)	3.80±1.11**	4.20±0.91*	4.30±0.42*	7.20±0.40	6.13±0.36

^*P<0.05,

^**P<0.01 compared to control postprandial values (7.10±0.29 μmol g fresh liver⁻¹).